Directory
>
Debora Bonenfant
Debora Bonenfant
Vice-President, Head of Proteomics | Monte Rosa Therapeutics
Basel, Basel-City, Switzerland
Debora Bonenfant
Summary
Debora Bonenfant is an accomplished VP and Global Head of Proteomics at Monte Rosa Therapeutics, with over twenty years of experience in drug discovery within the pharmaceutical and biotech industries. She has a robust expertise in biochemistry and proteomics, having developed innovative approaches to support early discovery targets across various therapeutic areas. Debora's career is marked by her leadership in building a Proteomics platform and her contributions to significant projects in drug discovery. She has received the Novartis Catalyst Award for her outstanding work. Fluent in English, Spanish, and French, she is well-equipped to navigate international collaborations. Her academic background includes a PhD from the University of Basel, where she specialized in biochemistry. Debora is not only a key player in her field but also actively contributes to scientific literature, showcasing her commitment to advancing proteomics research.
Debora Bonenfant
Work Experience
Vice-President, Head of Proteomics at
Monte Rosa Therapeutics
March 2023 - Present
Senior Director at
Monte Rosa Therapeutics
March 2022 - Present
Director of Proteomics at
Monte Rosa Therapeutics
September 2019 - February 2022
Senior Research Investigator at
Novartis
January 2014 - November 2021
Member of board at
Swiss Proteomics Society
January 2017 - November 2021
Research Investigator at
Novartis
December 2006 - January 2014
Post-Doctoral Fellow at
Novartis Institutes For Biomedical Research
November 2003 - November 2007
Debora Bonenfant
Education
University of Basel, Biozentrum, Doctor Of Philosophy (Phd)
January 1999 - January 2003
University of Toulouse , Dea (Masters Degree)
January 1998 - January 1999
Frequently Asked Questions about Debora Bonenfant
What is Debora Bonenfant email address?
Debora Bonenfant's primary email address is **********@monterosatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Debora Bonenfant work for?
Debora Bonenfant is a Vice-President, Head of Proteomics at Monte Rosa Therapeutics, a company specializing in Commercial physical research.
Where Debora Bonenfant graduated from?
Debora Bonenfant holds a degree in Biochemistry from University of Basel, Biozentrum.
How can I directly contact Debora Bonenfant?
To contact Debora Bonenfant directly, you can use the email address **********@monterosatx.com. Complete contact information is available upon registration with Muraena.
Who is Debora Bonenfant?
Debora Bonenfant is an accomplished VP and Global Head of Proteomics at Monte Rosa Therapeutics, with over twenty years of experience in drug discovery within the pharmaceutical and biotech industries. She has a robust expertise in biochemistry and proteomics, having developed innovative approaches to support early discovery targets across various therapeutic areas. Debora's career is marked by her leadership in building a Proteomics platform and her contributions to significant projects in drug discovery. She has received the Novartis Catalyst Award for her outstanding work. Fluent in English, Spanish, and French, she is well-equipped to navigate international collaborations. Her academic background includes a PhD from the University of Basel, where she specialized in biochemistry. Debora is not only a key player in her field but also actively contributes to scientific literature, showcasing her commitment to advancing proteomics research.
Debora`s contact details
**********@monterosatx.com
Colleagues
Chief Medical Officer
VP - Corporate Controller, Principal Accounting Officer
Vice President of Quality
Vice President, Chemistry at Monte Rosa Therapeutics
VP Oncology
Vice President, Discovery Sciences
VP of Nonclinical Development & Clinical Pharmacology
Chief Information Officer
Chief Operating Officer
Vice President